Swiss regulator and media clash over weight-loss drugs
This content was published on
Swissmedic has taken legal action against media for alleged unauthorised advertising of weight-loss drugs. Swiss media say this is censorship.
Medicines regulators weigh hope and hype with new Alzheimer’s drugs
This content was published on
Swissmedic is expected to decide on the approval of the first new drug for Alzheimer’s disease in two decades. The decision won’t be easy.
This content was published on
Sales of counterfeit drugs are booming around the world, putting thousands of lives at risk. Why is it so hard to stem the tide of fake medicine?
